DT

Dianthus Therapeutics

MA - Waltham
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: Monoclonal Antibodies

Dianthus Therapeutics is a life sciences company focused on Monoclonal Antibodies.

NeurologyImmunology
Open Jobs
5

Pipeline & Clinical Trials

Phase 2
Clinical Trials (1)
NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
Phase 2
Phase 2
Clinical Trials (1)
NCT06282159A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
Phase 2
Phase 3
Clinical Trials (1)
NCT06858579A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Phase 3

Open Jobs (5)

Executive Director / Vice President, Project Management

Program Management
2w ago

Director, Medical Writing

Regulatory Affairs
1mo ago

Director, Talent Acquisition

Human Resources
1mo ago

Medical Director, Drug Safety and Pharmacovigilance

Drug Safety
3mo ago

Clinical Development Medical Director - EMEA / UK

United Kingdom
Medical Affairs
4mo ago
Interview Prep Quick Facts
Portfolio: 3 clinical trials
H-1B (2023): 1 approval
Open Roles: 5 active jobs

Hiring Trend

Stable
5
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub